U.S. markets closed
  • S&P Futures

    4,173.50
    -10.00 (-0.24%)
     
  • Dow Futures

    34,644.00
    -24.00 (-0.07%)
     
  • Nasdaq Futures

    13,295.00
    -61.75 (-0.46%)
     
  • Russell 2000 Futures

    2,197.00
    -12.60 (-0.57%)
     
  • Crude Oil

    64.70
    -0.22 (-0.34%)
     
  • Gold

    1,835.20
    -2.40 (-0.13%)
     
  • Silver

    27.36
    -0.13 (-0.48%)
     
  • EUR/USD

    1.2133
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    1.6020
    +0.0250 (+1.59%)
     
  • Vix

    19.66
    +2.97 (+17.80%)
     
  • GBP/USD

    1.4117
    -0.0005 (-0.03%)
     
  • USD/JPY

    108.9590
    +0.1180 (+0.11%)
     
  • BTC-USD

    55,594.22
    -3,186.73 (-5.42%)
     
  • CMC Crypto 200

    1,461.37
    -99.92 (-6.40%)
     
  • FTSE 100

    7,123.68
    -6.03 (-0.08%)
     
  • Nikkei 225

    29,024.21
    -494.13 (-1.67%)
     

Biogen to pay $22 million to resolve U.S. drug charity kickback probe

  • Oops!
    Something went wrong.
    Please try again later.

BOSTON, Dec 17 (Reuters) - Biogen Inc has agreed to pay $22 million to resolve U.S. allegations that it illegally used two charities that help cover Medicare patients' out-of-pocket drug costs as a means to pay them kickbacks to use its multiple sclerosis drugs.

The deal, announced by the U.S. Justice Department on Thursday, was the latest to result from an industry-wide probe of drugmakers' financial support of patient assistance charities that has resulted in more than $1 billion in settlements. (Reporting by Nate Raymond in Boston)